D.S. Williamson

1.7k total citations
26 papers, 1.2k citations indexed

About

D.S. Williamson is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, D.S. Williamson has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in D.S. Williamson's work include Computational Drug Discovery Methods (5 papers), Radical Photochemical Reactions (5 papers) and Heat shock proteins research (4 papers). D.S. Williamson is often cited by papers focused on Computational Drug Discovery Methods (5 papers), Radical Photochemical Reactions (5 papers) and Heat shock proteins research (4 papers). D.S. Williamson collaborates with scholars based in United Kingdom, Denmark and Germany. D.S. Williamson's co-authors include P. Dokurno, James B. Murray, Geraint L. Francis, Martin J. Drysdale, T. Shaw, Yikang Wang, Alba T. Macias, Rachel Parsons, Andrew J. Massey and Mike Wood and has published in prestigious journals such as Chemical Communications, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

D.S. Williamson

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.S. Williamson United Kingdom	16	693	272	193	118	95	26	1.2k
Yinyan Tang United States	15	1.3k 1.9×	327 1.2×	97 0.5×	153 1.3×	51 0.5×	23	1.9k
P. Vedantham United States	11	699 1.0×	191 0.7×	386 2.0×	134 1.1×	102 1.1×	16	1.4k
Hiroki Tsumoto Japan	25	1.4k 1.9×	377 1.4×	97 0.5×	44 0.4×	66 0.7×	69	2.0k
Wilian A. Cortopassi United States	16	537 0.8×	187 0.7×	33 0.2×	145 1.2×	87 0.9×	29	1.0k
Roland W. Bürli United States	23	970 1.4×	525 1.9×	59 0.3×	56 0.5×	40 0.4×	54	1.5k
Nicolas Pietrancosta France	20	468 0.7×	338 1.2×	63 0.3×	97 0.8×	17 0.2×	63	1.0k
Michelle L. Lamb United States	22	1.2k 1.7×	453 1.7×	138 0.7×	506 4.3×	46 0.5×	37	1.9k
Graham M. West United States	18	1.2k 1.7×	143 0.5×	109 0.6×	142 1.2×	11 0.1×	31	1.7k
O.V. Gnedenko Russia	17	518 0.7×	76 0.3×	89 0.5×	89 0.8×	34 0.4×	77	887
Mattia Sturlese Italy	21	939 1.4×	285 1.0×	32 0.2×	395 3.3×	76 0.8×	85	1.4k

Countries citing papers authored by D.S. Williamson

Since Specialization

Citations

This map shows the geographic impact of D.S. Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.S. Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.S. Williamson more than expected).

Fields of papers citing papers by D.S. Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.S. Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.S. Williamson. The network helps show where D.S. Williamson may publish in the future.

Co-authorship network of co-authors of D.S. Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of D.S. Williamson. A scholar is included among the top collaborators of D.S. Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.S. Williamson. D.S. Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Williamson, D.S., et al.. (2024). Chemical shift prediction in 13C NMR spectroscopy using ensembles of message passing neural networks (MPNNs). Journal of Magnetic Resonance. 368. 107795–107795. 4 indexed citations

Williamson, D.S., Garrick P. Smith, Lassina Badolo, et al.. (2021). Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. Journal of Medicinal Chemistry. 64(14). 10312–10332. 23 indexed citations

Smith, Garrick P., Lassina Badolo, I‐Jen Chen, et al.. (2017). The design and SAR of a novel series of 2-aminopyridine based LRRK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(18). 4500–4505. 14 indexed citations

Christensen, Kenneth Vielsted, Garrick P. Smith, & D.S. Williamson. (2017). Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease. Progress in medicinal chemistry. 56. 37–80. 15 indexed citations

Thirstrup, Kenneth, Justus C. Dächsel, Felix Oppermann, et al.. (2017). Selective LRRK2 kinase inhibition reduces phosphorylation of endogenous Rab10 and Rab12 in human peripheral mononuclear blood cells. Scientific Reports. 7(1). 10300–10300. 73 indexed citations

Watson, Andrew D., et al.. (2014). 60MHz 1H NMR spectroscopy for the analysis of edible oils. TrAC Trends in Analytical Chemistry. 57(100). 147–158. 121 indexed citations

Macias, Alba T., D.S. Williamson, Nicola J. Allen, et al.. (2011). Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity. Journal of Medicinal Chemistry. 54(12). 4034–4041. 88 indexed citations

Gillespie, Roger J., Suneel Gaur, Philip S. Jackson, et al.. (2009). Antagonists of the human A2A receptor. Part 6: Further optimization of pyrimidine-4-carboxamides. Bioorganic & Medicinal Chemistry. 17(18). 6590–6605. 27 indexed citations

Massey, Andrew J., Helen Browne, Zoe Daniels, et al.. (2009). Abstract A212: A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor-induced apoptosis in HCT116 colon carcinoma cells. Molecular Cancer Therapeutics. 8(12_Supplement). A212–A212. 1 indexed citations

10.

Massey, Andrew J., D.S. Williamson, Helen Browne, et al.. (2009). A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells. Cancer Chemotherapy and Pharmacology. 66(3). 535–545. 241 indexed citations

11.

Scrace, Simon, Jenifer Borgognoni, Lan-Zhen Wang, et al.. (2008). Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked. Cell Cycle. 7(24). 3898–3907. 15 indexed citations

12.

Gillespie, Roger J., Ian A. Cliffe, Claire Dawson, et al.. (2008). Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines. Bioorganic & Medicinal Chemistry Letters. 18(9). 2924–2929. 55 indexed citations

13.

Gillespie, Roger J., Ian A. Cliffe, Claire Dawson, et al.. (2008). Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 18(9). 2920–2923. 24 indexed citations

14.

Richardson, Christine M., D.S. Williamson, Martin J. Parratt, et al.. (2007). Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping. Bioorganic & Medicinal Chemistry Letters. 17(14). 3880–3885. 38 indexed citations

15.

Richardson, Christine M., Roger J. Gillespie, D.S. Williamson, et al.. (2006). Identification of non-furan containing A2A antagonists using database mining and molecular similarity approaches. Bioorganic & Medicinal Chemistry Letters. 16(23). 5993–5997. 17 indexed citations

16.

Richardson, Christine M., D.S. Williamson, Martin J. Parratt, et al.. (2005). Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR. Bioorganic & Medicinal Chemistry Letters. 16(5). 1353–1357. 56 indexed citations

17.

Williamson, D.S., Martin J. Parratt, Justin Bower, et al.. (2005). Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2. Bioorganic & Medicinal Chemistry Letters. 15(4). 863–867. 60 indexed citations

18.

Baldwin, Jack E., Gareth J. Pritchard, & D.S. Williamson. (2001). The synthesis of 4-arylsulfanyl-substituted kainoid analogues from trans-4-hydroxy-l-proline. Tetrahedron. 57(37). 7991–7997. 11 indexed citations

19.

Baldwin, Jack E., Gareth J. Pritchard, & D.S. Williamson. (2000). The Synthesis of 4-Arylsulfanyl-substituted Kainoid Analogues from trans-4-Hydroxy-l-proline. Bioorganic & Medicinal Chemistry Letters. 10(17). 1927–1929. 12 indexed citations

20.

McCague, Raymond, Robin G. Pritchard, Richard J. Stoodley, & D.S. Williamson. (1998). Practical radical cyclisations leading to the construction of near-stereopure quaternary carbon stereogenic centres. Chemical Communications. 2691–2692. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact